Mengqi Tu
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 detection and testing 1
-
- Epigenetics and DNA Methylation 1
- Co-authors
- Haibo Xu (7 shared papers)Minhua Yu (3 shared papers)Wei Zhou (2 shared papers)Wen Zeng (3 shared papers)Danyang Chen (3 shared papers)Min Wang (2 shared papers)Liang Guo (3 shared papers)Sichao Chen (3 shared papers)
In The Last Decade
Mengqi Tu
12 papers receiving 411 citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 162
- Neurology 48
- Cancer Research 41
- Radiology, Nuclear Medicine and Imaging 60
- Genetics 26
Countries citing papers authored by Mengqi Tu
This map shows the geographic impact of Mengqi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengqi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengqi Tu more than expected).
Fields of papers citing papers by Mengqi Tu
This network shows the impact of papers produced by Mengqi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengqi Tu. The network helps show where Mengqi Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengqi Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 166 | |
| 2 | 2020 | 54 | |
| 3 | 2020 | 37 | |
| 4 | 2018 | 36 | |
| 5 | 2017 | 32 | |
| 6 | 2018 | 27 | |
| 7 | 2017 | 23 | |
| 8 | 2015 | 20 | |
| 9 | 2020 | 18 | |
| 10 | 2022 | 3 | |
| 11 | Long Non-Coding RNA PART1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells via miR-149-5p/MAP2K1 Axis | 2020 | 1 |
| 12 | 2020 | 1 | |
| 13 | 2025 | 0 |
About Mengqi Tu
Mengqi Tu is a scholar working on Infectious Diseases, Molecular Biology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 13 papers that have together received 418 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Cancer-related molecular mechanisms research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Plant and Fungal Interactions Research (1 paper), Epigenetics and DNA Methylation (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), MRI in cancer diagnosis (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Infectious Diseases (162 citations), Neurology (48 citations), Cancer Research (41 citations), Radiology, Nuclear Medicine and Imaging (60 citations) and Genetics (26 citations). Mengqi Tu has collaborated with scholars based in China, Maldives and Hong Kong. Frequent co-authors include Haibo Xu, Minhua Yu, Wei Zhou, Wen Zeng, Danyang Chen, Min Wang, Liang Guo, Sichao Chen, Zeming Liu and Lin Zhou. Their work appears in journals such as Radiology Cardiothoracic Imaging, Travel Medicine and Infectious Disease, Medicine, International Journal of Colorectal Disease and Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.